CDH1 and neoplasm: Loss of E-cadherin leads to a loss of epithelial differentiation and the acquisition of motility and an invasiveness phenotype, and its loss is associated with progression and poor prognosis of CRC, tumor invasiveness, metastases, and increased resistance to apoptosis.